Etudes scientifiques *2011*mutations of mortality: PARP again: "I have already written about PARP inhibitors here so this will be a follow up for some. A paper in the November 25th Blood tells of the pre-..."
*2011*mutations of mortality: RIC allografting in CLL: "A long time ago I promised to review the German experience with reduced intensity conditioning allograft in CLL which was published in the O..."
*2011*mutations of mortality: Gleevec for CLL: "Mcl-1 is one of those anti-apoptotic proteins that belong to the bcl-2 family. It may well be the most important in CLL. A paper from Liverp..."
*2010*mutations of mortality: UK CLL Trials meeting: "Although I wasn't well enough to attend the last Clinical Trials meeting of the UK CLL sub-group I did receive the agenda. I was impressed b..."
*2010* mutations of mortality: German CLL8 Part 1: "The German CLL8 trial by Hallek et al in today's Lancet is the most important CLL paper published for a decade. Why? Like most chronic lym..."
*2010* mutations of mortality: German CLL8 trial 2: "What sort of trial is the German CLL8 trial? It is an open label, randomized phase III trial. First it is 'open label'. This means that bot..."
*2010*mutations of mortality: German CLL8 Part 3: "This is a trial designed to see whether adding the anti-CD20 antibody, rituximab, to the previous gold-standard regimen of fludarabine and c..."
etc aller sur le site de Dr Terry Hamblin et faire une recherche avec code CLL8
*2009*mutations of mortality: ASH 2009: "It is now possible to view the ASH abstracts for 2009. Although I have already broken the news that for the first time a first line treatmen..."
*2009*mutations of mortality: Other trials in CLL: "I managed to attend my first Committee meeting yesterday. I went to London to meet with other CLL experts to discuss the forthcoming British..."
*2008*mutations of mortality: ASH 1 - The German CLL8 trial: "For CLL patients and doctors alike, the main event at ASH was the German CLL8 trial comparing FC with FCR. We already knew from the Roche we..."
*2008*mutations of mortality: Leukemia Research: "When I attend a committee that awards grants to researchers, I am of course sworn to secrecy about what goes on there, but I can blog about ..."
*2008*mutations of mortality: New Trials: "No blogging yesterday as I was at the UK CLL group's clinical trials meeting. This was a good chance to review what was happening in the UK...."
*2008*mutations of mortality: More from EHA on CLL: "At the recent EHA meeting at Copenhagen, Michael Hallek reported on current therapeutic options for CLL. He emphasised that most patients en..."
*2008*mutations of mortality: CLL latest news from EHA: "I have just listened to a podcast by Jesper Jurlander from the recent EHA meeting from Copenhagen. Remember that he was the man who introduc..."
*2008*mutations of mortality: ERIC: how to understand CLL little by little: "The EHA meeting is on just now in Copenhagen. I went to Copenhagen on Thursday but only to attend the European Research Initiative on CLL (E..."
*2008*mutations of mortality: Drug-resistant chronic lymphocytic leukaemia: "After successful induction therapy, relapse is almost inevitable if no consolidation takes place and is still possible if consolidation has ..."
*2008*mutations of mortality: New Clinical Trials: "I was at the UKCLL Forum Clinical Trials Meeting yesterday. Here are some of the trials up and running or in development in the UK. CLL6 is..."
*2006*mutations of mortality: Chemotherapy combinations: "Whenever an oncologist finds two drugs that are both effective in a particular cancer, his natural inclination is to combine them. It makes ..."
*2006*mutations of mortality: Outcomes in clinical trials: "A recent paper in the New England Journal of Medicine has given us all something to think about. It did not concern CLL; rather it was about..."
Aucun commentaire:
Enregistrer un commentaire